SPONSOR
Shanghai Proton and Heavy Ion Center
Total Trials
2
Recruiting
2
Phases
N/A
Shanghai Proton and Heavy Ion Center is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Cancer, Proton Therapy, Pancreatic Cancer Non-resectable.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Proton and Heavy Ion Center
How many clinical trials has Shanghai Proton and Heavy Ion Center sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shanghai Proton and Heavy Ion Center, of which 2 are actively recruiting participants. These trials cover conditions including Breast Cancer, Proton Therapy, Pancreatic Cancer Non-resectable. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Proton and Heavy Ion Center research focus on?
Shanghai Proton and Heavy Ion Center clinical trials span Breast Cancer, Proton Therapy, Pancreatic Cancer Non-resectable. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Shanghai Proton and Heavy Ion Center clinical trial?
To participate in a Shanghai Proton and Heavy Ion Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Proton and Heavy Ion Center trials with current recruitment status updated daily.
Clinical Trials by Shanghai Proton and Heavy Ion Center
NCT07135661
Recruiting
Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy
Breast Cancer
NCT05424159
Recruiting
Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer
Pancreatic Cancer Non-resectable
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology